Cold Spring Harbor Lab Discovery Could Revolutionize Estrogen Receptor-Positive Breast Cancer Treatment

Breast Cancer Research Breakthrough

• 💡 Researchers at Cold Spring Harbor Laboratory are exploring a new discovery that could significantly change treatment for estrogen receptor-positive breast cancer.
• 🎯 This type of cancer, which accounts for about 75% of cases, relies on estrogen to fuel the growth of cancerous cells.

Inhibiting Gene Protein in Mice

• 🔬 A team led by Professor Camila Dos Santos has successfully inhibited a gene protein in mice, which showed promise in slowing or stopping the growth of estrogen receptor-positive breast cancers.
• 🧬 The research also investigates changes in the breast during puberty, following individuals over time.

Addressing Recurrence and Treatment Resistance

• ⚠️ A significant challenge in breast cancer treatment is recurrence, where tumors that were initially estrogen hormone negative can become positive, making them untreatable with standard hormone therapy like tamoxifen.
• 🔑 The new research aims to make tumors more susceptible to targeted therapies and potentially prevent metastatic disease.

Hope for Survivors and Earlier Diagnosis

• ✨ Survivors like Susan Cohen and Janine Mullen express hope that this research could lead to a future without the fear of recurrence and the arduous treatment process.
• 🔍 The ongoing mission includes refining methods for earlier diagnosis and identifying warning signs before physical symptoms or mammogram/ultrasound detection.